HUNTINGTON (HBAN) Director reports acquisition of 800.06 shares

Katherine M. A. Kline, a Director of Huntington Bancshares Inc. (HBAN), filed a Form 4 reporting transactions dated 10/01/2025.

Rhea-AI Filing Summary

Katherine M. A. Kline, a Director of Huntington Bancshares Inc. (HBAN), filed a Form 4 reporting transactions dated 10/01/2025. The filing reports the acquisition of 800.06 shares of common stock and an additional acquisition of 44.026 shares attributable to a director deferred compensation plan, both shown at a price of $0.0000. After the reported transactions, the filing lists 88,755.371 shares as directly beneficially owned and 4,927.986 shares as indirectly beneficially owned via the deferred compensation plan.

The Form 4 identifies the reporting persons address as Huntington Center, 41 S. High Street, Columbus, OH 43215 and includes an exhibit index reference to a substitute power of attorney. The filing contains the signature of an attorney-in-fact dated 10/03/2025. The statement clarifies that the filing is not an admission of beneficial ownership for Section 16 purposes.

Insights

Corporate Governance Expert

Director reported small share issuances and holds significant direct and indirect positions.

The Form 4 documents that Katherine M. A. Kline acquired 800.06 shares directly and 44.026 shares via a director deferred compensation plan on 10/01/2025, both recorded at $0.0000.

After these transactions, the filing discloses 88,755.371 shares held directly and 4,927.986 shares held indirectly. These figures are relevant to ownership disclosure and insider tracking but do not, by themselves, indicate changes to control or material shifts in governance.

Insider Trade Summary

Grant/Award: 844.086 shares

Grant/Award 2 txns

Insider Kline Katherine M. A.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	800.06	$0.00	$0.00
Grant/Award	Common Stock	44.026	$0.00	$0.00

Holdings After Transaction: Common Stock — 88,755.371 shares (Direct); Common Stock — 4,927.986 shares (Indirect, Director Deferred Compensation Plan)

Footnotes (1)

1. F1. The filing of this statement shall not be construed as an admission that the undersigned is, for the purpose of Section 16 of the Securities and Exchange Act of 1934 or otherwise, the beneficial owner of the securities.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did HBAN director Katherine Kline report on the Form 4?

The Form 4 reports the acquisition of 800.06 common shares and 44.026 shares via a director deferred compensation plan, dated 10/01/2025.

How many HBAN shares does Katherine Kline beneficially own after the transaction?

The filing lists 88,755.371 shares as directly beneficially owned and 4,927.986 shares as indirectly beneficially owned.

At what price were the reported HBAN shares acquired?

Both reported acquisitions are recorded at a price of $0.0000 in the Form 4.

When were the Form 4 transactions and signature dated?

Transactions are dated 10/01/2025 and the filing is signed by an attorney-in-fact on 10/03/2025.

What relationship does the reporting person have to HBAN?

The Form 4 indicates the reporting person, Katherine M. A. Kline, is a Director of HBAN.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 10/03/2025 - 04:10 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Kline Katherine M. A.

(Last) (First) (Middle)

HUNTINGTON CENTER

41 S. HIGH STREET

(Street)

COLUMBUS OH 43215

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
HUNTINGTON BANCSHARES INC /MD/ [ HBAN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
10/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/01/2025		A		800.06	A	$0.0000	88,755.371	D
Common Stock	10/01/2025		A		44.026	A	$0.0000	4,927.986	I	Director Deferred Compensation Plan(1)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The filing of this statement shall not be construed as an admission that the undersigned is, for the purpose of Section 16 of the Securities and Exchange Act of 1934 or otherwise, the beneficial owner of the securities.

Remarks:

EXHIBIT INDEX Exhibit 24 - Substitute Power of Attorney

	Rachel L. Lawless, Attorney-in-Fact	10/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.